NCT02318355

Brief Summary

This study is a randomized control trial in volunteer blood donors to quantify the effect of blood loss and subsequent crystalloid infusion on hemoglobin and markers of resuscitation such as base deficit and lactate.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
165

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2013

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 10, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 17, 2014

Completed
Last Updated

April 21, 2022

Status Verified

December 1, 2014

Enrollment Period

7 months

First QC Date

December 10, 2014

Last Update Submit

April 19, 2022

Conditions

Keywords

hemodilutionhemorrhagetraumalactatebase deficitrandomized control trial

Outcome Measures

Primary Outcomes (1)

  • Hemoglobin (g/dL)

    obtain hemoglobin immediately before and after donation, and after resuscitation with intravenous fluids. From donation to end of resuscitation, the time frame will be 2 hours or less. Donors will not be followed after the third blood draw and will be discharged from the study. No follow-up was obtained.

    2 hours

Secondary Outcomes (2)

  • Lactate (mmol/L)

    2 hours

  • Base deficit (mmol/L)

    2 hours

Study Arms (3)

Control

NO INTERVENTION

Control group that receives no intravenous fluid after blood donation

Lactated Ringers

EXPERIMENTAL

Experimental group that receives two liters lactated ringers after blood donation.

Other: lactated ringers

Normal Saline

EXPERIMENTAL

Experimental group that receives two liters normal saline after blood donation.

Other: normal saline

Interventions

Crystalloid intravenous solution

Also known as: NS
Normal Saline

Crystalloid intravenous solution

Also known as: LR
Lactated Ringers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • able to donate 500cc blood
  • age \> or = 18

You may not qualify if:

  • unable to obtain IV access
  • multiple blood draws fail to run on laboratory assays

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Ross SW, Christmas AB, Fischer PE, Holway H, Seymour R, Huntington CR, Heniford BT, Sing RF. Defining Dogma: Quantifying Crystalloid Hemodilution in a Prospective Randomized Control Trial with Blood Donation as a Model for Hemorrhage. J Am Coll Surg. 2018 Sep;227(3):321-331. doi: 10.1016/j.jamcollsurg.2018.05.005. Epub 2018 Jun 4.

  • Ross SW, Christmas AB, Fischer PE, Holway H, Walters AL, Seymour R, Gibbs MA, Heniford BT, Sing RF. Impact of common crystalloid solutions on resuscitation markers following Class I hemorrhage: A randomized control trial. J Trauma Acute Care Surg. 2015 Nov;79(5):732-40. doi: 10.1097/TA.0000000000000833.

MeSH Terms

Conditions

HemorrhageShockWounds and Injuries

Interventions

Saline SolutionRinger's Lactate

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Ronald F Sing, DO

    Professor of Surgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2014

First Posted

December 17, 2014

Study Start

November 1, 2013

Primary Completion

June 1, 2014

Study Completion

June 1, 2014

Last Updated

April 21, 2022

Record last verified: 2014-12